{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2"}]}],"title":"Transplantation-related mortality 0-100 days"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Transplantation-related mortality 100-365 days"}],"denoms":[{"counts":[{"groupId":"OG000","value":"35"}],"units":"Participants"}],"groups":[{"description":"Conditioning with Alemtuzumab, busulfan and fludarabine followed by allogeneic hematopoietic cell transplant.","id":"OG000","title":"Single Arm - Transplant Pre-conditioning Per Study Protocol"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"100 days and 1 year","title":"Treatment-related Mortality at 100 Days and 1 Year Post Transplantation","type":"SECONDARY","unitOfMeasure":"participants"}